Conversation with The Cancer Letter Paige’s Razik Yousfi: Biden has set expectations for AI, but details will come via federal guidelines November 17, 2023Vol.49 No.43By Matthew Bin Han Ong
Regulatory News ODAC reviews two longest-running accelerated approvals as FDA weighs using its new authority November 17, 2023Vol.49 No.43By Jacquelyn Cobb
Drugs & Targets FDA approves Keytruda + chemo for HER2-negative gastric or GEJ cancer November 17, 2023Vol.49 No.43
Drugs & Targets FDA approves Edison histotripsy device to treat liver tumors November 17, 2023Vol.49 No.43
Drugs & Targets FDA approves Fruzaqla for previously treated metastatic CRC November 10, 2023Vol.49 No.42
